- Research works
- 42 ▲ 38% vs 2018-21
- Citations
- 1.1k 25.6 per fractional work
- Top-10% rate
- 7.8% all institutions 10.0%
- Open access
- 59% world 40%
- International
- 16% world 18%
Not ranked overall: Selecta Biosciences (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Selecta Biosciences (United States) work in?
In all years, 62% of research at Selecta Biosciences (United States) is in Life Sciences, 32% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (33%), Medicine (32%), Immunology and Microbiology (26%). It does 3.1× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 13 fields, with their numbers
- Life Sciences2661.5%
- Health Sciences1432.3%
- Medicine1331.5%
- Nursing00.5%
- Veterinary00.2%
- Physical Sciences25.4%
- Chemistry13.2%
- Environmental Science01.0%
- Engineering00.7%
- Computer Science00.5%
- Mathematics00.1%
- Social Sciences00.8%
- Psychology00.8%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 9.0×. Every wedge is a field page.
All 11 fields, with their numbers
- Biochemistry, Genetics and Molecular Biology8.97×9 works
- Veterinary3.38×0 works
- Immunology and Microbiology2.92×0 works
- Neuroscience2.26×1 works
- Chemistry1.87×0 works
- Nursing1.87×0 works
- Medicine1.81×6 works
- Psychology0.60×0 works
- Agricultural and Biological Sciences0.33×0 works
- Environmental Science0.28×0 works
- Engineering0.10×0 works
Who are the top researchers at Selecta Biosciences (United States)?
Ranked on the quality score, Lloyd P. M. Johnston, Christopher J. Roy and Robert H. Meltzer lead among researchers whose main affiliation is Selecta Biosciences (United States).
- 1
Lloyd P. M. Johnston
United States · #537,902 worldwide 1k citations · 24 works
- 2
Christopher J. Roy
United States · #1,550,840 worldwide 953 citations · 19 works
- 3
Robert H. Meltzer
United States · #3,434,442 worldwide 446 citations · 24 works
Which keywords describe research at Selecta Biosciences (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Antigen Presentation, Immunity, Innate Immunity, Dendritic Cells, Tumor Antigen, Gene Therapy and Autoimmunity.
- Lipid Metabolism
- Cancer Progression
- Angiogenesis
- Gene Expression
- Genome Engineering
- siRNA Delivery
- Chimeric Antigen Receptor
- Targeted Therapy
- Therapeutic Antibodies
- Antibody Engineering
- Viral Vectors
- AAV
- Immunotherapy
- Natural Killer Cells
- Foxp3
- Inflammation
- Tumor Antigen
- Innate Immunity
- Antigen Presentation
- Cancer Immunotherapy
- Immunity
- Dendritic Cells
- Gene Therapy
- Autoimmunity
- NK Cell Recognition
- TGF-ß
- Cancer Therapy
- Glycosylation
- Monoclonal Antibodies
- Fc Receptors
- Tumor Microenvironment
- CAR T Cells
- RNA Interference
- Cancer
- RNA-Guided
- Metabolic Syndrome
- Epidemiology
- Fatty Acid Synthase
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 38 words, with their numbers
- Cancer Immunotherapy6▲ 98×2 topics
- Antigen Presentation5▲ 113×2 topics
- Immunity5▲ 32×2 topics
- Innate Immunity4▲ 30×2 topics
- Dendritic Cells4▲ 88×1 topic
- Tumor Antigen4▲ 124×1 topic
- Gene Therapy4▲ 36×5 topics
- Inflammation3▲ 2.7×11 topics
- Autoimmunity3▲ 30×2 topics
- Foxp32▲ 78×1 topic
- NK Cell Recognition2▲ 57×1 topic
- Natural Killer Cells2▲ 57×1 topic
- TGF-ß2▲ 34×1 topic
- Immunotherapy2▲ 8.6×4 topics
- Cancer Therapy2▲ 8.3×4 topics
- AAV2▲ 76×1 topic
- Glycosylation2▲ 22×2 topics
- Viral Vectors2▲ 76×1 topic
- Monoclonal Antibodies2▲ 31×3 topics
- Antibody Engineering2▲ 40×1 topic
- Fc Receptors2▲ 40×1 topic
- Therapeutic Antibodies2▲ 32×2 topics
- Tumor Microenvironment2▲ 11×4 topics
- Targeted Therapy2▲ 17×4 topics
- CAR T Cells2▲ 83×1 topic
- Chimeric Antigen Receptor2▲ 83×1 topic
- RNA Interference2▲ 31×1 topic
- siRNA Delivery2▲ 46×1 topic
- Cancer1▲ 2.4×5 topics
- Genome Engineering1▲ 54×1 topic
- RNA-Guided1▲ 54×1 topic
- Gene Expression1▲ 4.8×3 topics
- Metabolic Syndrome1▲ 3.4×2 topics
- Angiogenesis1▲ 6.1×3 topics
- Epidemiology1▼ 0.62×9 topics
- Cancer Progression1▲ 10×2 topics
- Fatty Acid Synthase1▲ 60×1 topic
- Lipid Metabolism1▲ 60×1 topic
Which research topics does Selecta Biosciences (United States) publish most on?
By volume in 2022-now: CAR-T cell therapy research, Virus-based gene therapy research, Cancer, Lipids, and Metabolism and CRISPR and Genetic Engineering.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 1 works
- 2 Virus-based gene therapy research Genetics 1 works
- 3 Cancer, Lipids, and Metabolism Cancer Research 1 works
- 4 CRISPR and Genetic Engineering Molecular Biology 1 works
- 5 Signaling Pathways in Disease Molecular Biology 1 works
- 6 Peptidase Inhibition and Analysis Oncology 1 works
- 7 RNA Interference and Gene Delivery Molecular Biology 1 works
- 8 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
- 9 Cancer Genomics and Diagnostics Cancer Research 1 works
- 10 Hematopoietic Stem Cell Transplantation Hematology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Selecta Biosciences (United States)'s research output changed?
Output in 2022-2025 was 38% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Selecta Biosciences (United States) as a percentage of every work published that year, 0.00016% in 2024.
Fractional works of Selecta Biosciences (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Watertown
- Boston Biomedical Research Institute
- Primary Source
- Cambridge Scientific (United States)
- Radiation Monitoring Devices (United States)
- Arsenal Medical (United States)
- Pathfinder International
- New England Research Institutes
- Perkins School for Blind
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Selecta Biosciences (United States). Posts are plain text and can be reported.